Generation of adult human T-cell progenitors for immunotherapeutic applications by Simons, Laura et al.
 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
J ALLERGY CLIN IMMUNOL
VOLUME 141, NUMBER 4
LETTERS TO THE EDITOR 1491purified natural Amb a 1.01 is capable of inducing strong TH2 im-
mune responses in mice in the absence of (extrinsic) adjuvants. In
contrast, under the same conditions, the nonallergenic bacterial ho-
mologue induced a TH1-biased response. Our data on Amb a 1.01
and DC-pelC are in agreement with previous findings for fold-
stabilized Bet v 1 mutants.8 Thus, we propose a model in which
the intrinsic stability/susceptibility of a protein to proteolysis can
directly influence its processing and determines the intensity andpo-
larization of the ensuing immune response (Fig 2, C).
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progenitors for immunotherapeutic
applicationsTo the Editor:
ProlongedT-cell deficiencywith subsequent high risk of infection
and relapse is a major complication of non-HLA identical hemato-
poietic stem cell transplantation (HSCT).1 Complete restoration of a
polyclonalT-cell repertoire takes up to2years andmightnever reach
pretransplantation levels.2 Even in T cell–replete HSCTs, homeo-
static cytokines trigger a first peripheralwave ofCD81Tcells, lead-
ing to a skewing of the T-cell receptor (TCR) repertoire,3 and
reconstitution of a fully functionalT-cell compartment relies on pro-
duction of newnaive T cells. Adoptive transfer of in vitro–generated
T lymphoid precursors provides a promising approach to overcome
this hurdle and ameliorate T-cell reconstitution after HSCT.4
Considering the known role of Notch signaling in T-cell lineage
differentiation in mice and human subjects,5 we have imple-
mented a feeder cell–free culture system based on the immobi-
lized Notch ligand delta-like (DL) 4 in combination with a
specific set of cytokines.6 Compared with previously described
feeder-free systems, our DL-4 culture is more efficient and highly
reproducible when applied to cord blood (CB) hematopoietic
stem and progenitor cells (HSPCs).7 Moreover, our system is
currently in the process of being approved for clinical application.
Mobilized peripheral blood (mPB) is currently the main source
of HSPCs in allogeneic HSCTs because adult HSPCs are avail-
able in large quantities and exhibit several advantages over CB
grafts in the clinical setting.8 However, their intrinsic properties of
differentiation, survival, and proliferation have been investigated
poorly thus far. Here we demonstrate the production of T-cell pre-
cursors from adult mPB HSPCs in a feeder cell–free DL-4–based
in vitro system. All experimental procedures were performed as
described in the Methods section in this article’s Online Reposi-
tory at www.jacionline.org.
Peripheral blood–derived CD341 cells from granulocyte
colony-stimulating factor–mobilized (G-CSF) healthy donors
were cultured with DL-4 protein, and the phenotype of emerging
cell populationswas analyzed.As early as day3 in adultHSPCcul-
tures (Fig 1,A), expression of CD34 andCD7marked the presence
of an early thymic progenitor (ETP)-like population not detected in
control Fc cultures (see Fig E1 in this article’sOnlineRepository at
www.jacionline.org). In concordance with further T-lineage
commitment, precursors derived from adult HSPCs downregu-
lated CD34 at day 7, giving rise to a CD342CD711 cell pro-
FIG 1. Generation of T-cell progenitors from mPB CD341 HSPCs. A-C, Phenotype, frequency, and cell
numbers of day 3 and day 7 DL-4 cultures. D, Quantification of T-cell potential by T-cell differentiation on
OP9/DL-1 cells in limiting dilution conditions. E-I, Gene expression profile of day 0 CD341 cells and day 3
and day 7 CD71 cells by using quantitative RT-PCR (Fig 1, E-G) or day 3 and day 7 CD72 and CD71 cells
(Fig 1, H and I). *P < .05 and **P < .01.
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of CD71 cells was 2.5-fold greater than at day 3 (Fig 1, C).
We also quantified T-lineage potential by culture of day 0, 3,
and 7 DL-4 progenitors on OP9/DL-1 in limiting dilution assays
(LDA) (Fig 1, D). Based on the presence of CD41CD81 double-
positive cells or CD31 cells, the frequency of T-cell precursors
assessed by LDA reached mean 6 SEM values of 1/13.5 6 1/3.5
at day 3 and 1/18.9 6 1/6.6 at day 7. These values were similar
to values observed in day 7 CB DL-4 cultures and much greater
than the value in uncultured CD341 cells (1/9000).6
To further characterize adult-derived T-cell precursors, we
performed gene expression analysis of day 0 mPB HSPCs and
sorted CD71 fractions on days 3 and 7 of DL-4 cultures, focusing
on genes implicated in the Notch pathway, early lymphocyte
development, thymus homing, and T-lineage differentiation. Ma-
jor Notch target genes, such as DTX1, NRARP, and HES1, wereinduced after 3 days of DL-4 culture and remained stable there-
after (Fig 1, E). Gene expression analysis revealed that exposure
of mPBHSPCs to DL-4 led to (1) gradual downregulation of mul-
tipotency and early lymphoid development genes, such as CD34,
IKAROS,MYB, and KIT; (2) silencing of PAX5; and (3) induction
of crucial T-lineage differentiation genes, such as BCL11B,
IL7RA, and TCF7, all of which confirmed the proper induction
of a T-lineage program in CD71 cells not detected in CD72 cells
(Fig 1, F-H).9
Regarding expression of homing molecules, CXCR4 was
already expressed in adult CD341 HSPCs before culture (data
not shown). After 3 and 7 days of DL-4 culture, major chemokine
receptors potentially implicated in human thymus homing, such
as CCR7, CCR9, and CXCR4, were expressed at significantly
higher levels in the CD71 population when compared with the
CD72 fraction (Fig 1, I).
FIG 1. (Continued)
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tested by means of transplantation into nonirradiated newborn
NOD/SCID/gc2/2 (NSG) mice. Human thymic engraftment was
accelerated greatly, occurring at only 4 weeks in 3 of 3 mice in-
jected with day 7 DL-4 cells and persisting thereafter (Fig 2, A,
and see Table E1 in this article’s Online Repository at www.
jacionline.org). In contrast, we did not observe engraftment before
11 weeks after transplantation in recipients of untreated CD341
cells or day 3 DL-4 cells (Fig 2, A, and see Table E1). Active hu-
man thymopoiesis was further demonstrated by the presence of hu-
man CD41CD81 double-positive cells and enlarged thymic lobes
compared with recipients of uncultured adult HSPCs (Fig 2, B and
C). Mature CD31TCRab1 T cells displaying a polyclonal TCR
repertoire were detected in the thymi and spleens of recipient
mice 8 weeks after transplantation (Fig 2, C and D). Moreover,
we detected a small population of CD251CD41Foxp31CD1272
regulatory T cells in the spleens of injected mice (see Fig E2 in
this article’s Online Repository at www.jacionline.org).
Overall, our results show that adult HSPCs provide an effective
source of in vitro–cultured T-cell precursors harboring all thenecessary requirements for in vivo reconstitution of a functional
T-cell compartment. Based on these results, we have established
a clinical grade protocol to guide immunotherapeutic strategies
using T-cell precursors to fasten T-cell recovery in the adult trans-
plantation setting, where HSPCs from mPB are more available
and more frequently used than HSPCs from CB.We thank the animal house staff in the Transgenesis and Animal
Experimentation Laboratory at SFR Necker (Paris, France) for careful
handling of the mice. We thank Antoine Toubert, Emmanuel Clave, and
Ellen Rothenberg for fruitful discussions.
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FIG 2. In vivo reconstitution potential of T-cell precursors derived frommPB. A, Human thymic engraftment
evaluated by the frequency of human CD451 (hCD45) and mouse CD451 (mCD45) lymphocytes in NSG
recipients 6 weeks after transplantation with CD341 cells before (day 0) or after 3 or 7 days of culture in
DL-4 conditions. B, Presence of mature CD41CD81 double-positive cells in thymi of recipients transplanted
with day 7 DL-4–cultured progenitors. The picture shows a representative photograph of recipient thymi in-
jected with day 7 DL-4 cultured cells and day 0 HSPCs 8 weeks after transplantation. C, Presence of
CD31TCRab1 T cells in thymi and spleens of recipients injected with day 7 DL-4 cultured progenitors (gated
on hCD451 cells 8 weeks after transplantation). D, TCRb VJ diversity in splenocytes from NSG mice trans-
planted with day 7 DL-4–cultured cells (8 weeks after transplantation).
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mPB samples used in the study corresponded to the unused fraction of
grafts from 23 healthy donors mobilized with granulocyte colony-stimulating
factor who had provided informed consent for research use. mPB samples are
part of a collection authorized by the French Ministry of Research (DC-2014-
2272, 23rd March 2015).
CD341 HSPCs were sorted magnetically from mPB, as previously descri-
bed.E1 Purity was greater than 93%.
Cultures
CD341 cells were cultured in a-MEM medium (Gibco, Life Technology,
Carlsbad, Calif) in 24- or 6-well plates coated with RetroNectin (25 mg/mL;
Ozyme, Saint-Quentin-en-Yvelines, France) and DL-4 (5 mg/mL; PX’Thera-
peutics, Grenoble, France), as described previously.E2
The T-lymphoid potential of naive CD341 cells and T-cell precursors
generated by exposure to DL-4 was assessed by using a limiting dilution assay
in OP9/DL-1 cocultures, as previously described in 3 independent
experiments.E1
Flow cytometric analysis and cell sorting
Cells obtained after 3 (n5 36) or 7 (n5 19) days of culture were analyzed
by using flow cytometry. Monoclonal antibodies against human CD34
(AC136), CD3 (BW264/56), CD45 (5B1), CD4 (VIT4), and CD8 (BW135/
80) were purchased from Miltenyi Biotech (Bergisch Gladbach, Germany),
and CD4 (SK4), CD7 (M-T701), CD25 (M-A251), CD127 (HIL-7R-M21), 7-
aminoactinomycin D (7AAD) were from BD Biosciences (San Jose, Calif).
Anti-human CD8 (RPAT8) was from Sony Biotechnology (San Jose, Calif),
and Foxp3 (PCH101) and CD3 (UCHT1) were from eBioscience (San Diego,
Calif). TCRa/b (IP26A) and TCRgd (IMMU510) were from Beckman
Coulter (Brea, Calif).
Cells from xenogenic murine recipients were analyzed on a MACSQuant
apparatus (Miltenyi Biotech). Data were analyzed with FlowJo software
(version 10.2; TreeStar, Ashland, Ore) after gating on viable 7AAD2 cells.
Cell subsets were sorted on a FACSAria II system (BD Biosciences).
Cultured cells were sorted by using fluorescence-activated cell sorting after
3 and 7 days of culture on DL-4, respectively, to exclude CD342/CD72
myeloid cells from subsequent analysis. Cell subsets were sorted on BD FAC-
SAria II SORP system with a highly pure sorting modality (4-way purity),
achieving a purity of greater than 98%. The viability of sorted CD71 cells
measured by using 7AAD staining was 99.22% 6 0.17% (mean 6 SEM).
Quantitative real-time PCRs with the RT2 Profiler
array
Total RNA of 4 uncultured CD341 HSPCs and sorted CD71 cell fractions
from 6 day 3 and 7 day 7 samples was isolated with the RNeasy Micro Kit
(Qiagen, Courtaboeuf, France). RT2 Profiler PCR arrays for the Human Notch
Pathway and a custom-designed array, including lymphocyte and T-lineage
differentiation genes, were performed according to the protocol detailed in
the RT2 Profiler PCR Array Handbook (SA Biosciences, Frederick, Md).
Briefly, from a total RNA eluate volume of 16 mL, 8 mL was subjected to
genomic DNA elimination, cDNA synthesis, and preamplification by using
the RT2 PCR System (PreAMP system; SA Biosciences). Preamplified
cDNA samples were reverse transcribed with the RT2 First Strand Kit (SA
Biosciences), which includes an additional step of DNAse digestion to prevent
contamination of cDNAwith any genomic DNA. cDNAwas mixed with RT2
SYBR Green Mastermix and RNase-free water to make the PCR components
mix, which was then distributed in 25-mL aliquots across the RT2 Profiler PCR
Array. For the custom array, primers were synthesized by the manufacturer
(SA Biosciences) based on the list of gene names, symbols, and UniGene
and Genbank IDs. The plate was sealed and centrifuged to remove bubbles
and then run on an ABI Prism 7300 system (Applied Biosystems, Foster
City, Calif), according to the manufacturer’s instructions. All transcript levels
were normalized against the results for human hypoxanthine guanine phos-
phoribosyltransferase (HPRT). Normalization to the HPRT gene was per-
formed by calculating the D cycle threshold (Ct) for each gene of interest in
the plate (Ct value of the gene of interest Ct value of HPRT). Any Ct value
of greater than 35 was considered a negative call. If the Ct value of the
genomic DNA control was greater than 30, then no genomic DNAwas detect-
able. Negative controls remained unamplified throughout the study.
Data were processed by using the R package with the value log2 22DCt.
The nonsignificant different values based on the Pearson correlation coeffi-
cient were excluded. The heat map was created with Java Treeview software
(version 1.1; https://sourceforge.net/).
Adoptive transfer of in vitro–generated T-cell
precursors derived from adult HSPCs into NSG
neonates
NSG mice (obtained from the Jackson Laboratory, Bar Harbor, Me; http://
www.jax.org) were kept in a pathogen-free facility. Progeny derived from
mPB CD341 HSPCs in 3- or 7-day DL-4 cultures (3 3 105 or 1 3 106)
were injected intrahepatically into NSG neonates (0-4 days old; n 5 5 and
n 5 7 recipients undergoing transplantation with day 3 and day 7-cell prod-
ucts, respectively, in 3 independent experiments). Control mice were injected
with either 33 105 noncultured mPB CD341 cells (n5 9) or 100 mL of PBS
(n 5 13).
Human engraftment rates were determined from 4 to 16 weeks after
transplantation. Flow cytometric analysis was performed on fresh cells
collected from femur bone marrow, thymus, and spleen. Cells were treated
with 13 red blood cell lysis buffer (BioLegend, San Diego, Calif) and washed
before antibodies staining.
T-cell repertoire diversity was evaluated bymeans of determination of VDJ
gene rearrangements with the ImmunTraCkeR Kit (ImmuneID Technologies,
Grenoble, France) on genomic DNA extracted from splenocytes of NSG
recipient mice 8 weeks after transplantation with human DL-4–induced T-cell
precursors. Signals were measured by means of semiquantitative evaluation
on fluorescence intensity and analyzed by using ConstelID software
(ImmuneID Technologies, Grenoble, France).
The injection of human progenitors into NSG mice has been approved by
the Ministry of Higher Education and Research (APAFIS 2101-
2015090411495178v4; November 2, 2015).
Statistical analysis
The unpaired t test was used to compare differences in gene expression be-
tween mPB HSPCs and DL-4–induced T-cell precursors by using Prism soft-
ware (version 6; GraphPad Software, La Jolla, Calif).
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FIG E1. Phenotype of adult CD341 HSPCs exposed to 3 or 7 days of DL-4–Fc
fusion protein compared with Fc alone.
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FIG E2. Presence of human CD251CD41Foxp31CD1272 regulatory T cells in the spleens of NSG recipients
8 weeks after transplantation of adult day 7 DL-4 precursors. Cells were first gated on 7AAD2 live human
CD451 cells (left panel) and then on CD41CD251 cells (right panel).
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TABLE E1. Kinetics of thymic engraftment of DL-4–cultured progenitors after transplantation in NSG mice
Weeks after transplantation
Transplantation (no. of recipients) 4-5 6-7 8-10 11-16
Day 0 CD341 cells (n 5 9) 0/1 0/2 1/2 4/4
Day 3 DL-4 precursors (n 5 5) ND 1/2 0/1 4/4
Day 7 DL-4 precursors (n 5 7) 3/3 1/2 1/1 1/1
ND, Not determined.
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